SciELO - Scientific Electronic Library Online

 
vol.110 issue8Sweet syndrome after treatment with vedolizumab in a patient with Crohn's diseaseA pneumoperitoneum due to intestinal cystic pneumatosis associated with a tyrosine kinase inhibitor author indexsubject indexarticles search
Home Pagealphabetic serial listing  

My SciELO

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista Española de Enfermedades Digestivas

Print version ISSN 1130-0108

Rev. esp. enferm. dig. vol.110 n.8 Madrid Aug. 2018

https://dx.doi.org/10.17235/reed.2018.5599/2018 

LETTERS

Dyspepsia, functional dyspepsia and Rome IV criteria

Antonio-M.ª Caballero-Mateos1  , Eduardo Redondo-Cerezo1 

1Servicio de Aparato Digestivo. Hospital Virgen de las Nieves. Granada, Spain

Key words: Prevalence; Dyspepsia; Functional dyspepsia; Rome IV criteria

Dear Editor,

The definition of dyspepsia is only based on symptoms and chronology 1. When diagnostic tests are performed in order to find a cause, we talk about investigated dyspepsia. When we find an actual cause, we call it secondary or organic dyspepsia, and when every test is normal, functional dyspepsia (FD). There has been a huge effort since the establishment of the Rome I criteria (RC-I) until the present Rome IV (RC-IV) criteria 2 to define and gather the dyspeptic symptoms into GERD, irritable bowel disease and FD.

Aziz et al. recently reported that around one in every ten people within the general population (GP) in the USA (12%), Canada (8%) and UK (8%) fulfilled the RC-IV criteria for FD (5,931 people studied), resulting in an uninvestigated dyspepsia. These results indicate an overestimation of the actual prevalence of the FD in the GP. Bearing in mind that the numbers would decrease after performing an upper endoscopy 2, the prevalence of RC-IV FD is greater than the prevalence of actual FD. According to a previous study 4 of a random sample of 264 people from the GP (the prevalence of dyspepsia was 23.9% with CR-I), we found a pathological upper endoscopy in 28.6% of the dyspeptic individuals. Meaning that, 71.4% of cases had an FD and the prevalence of FD in our GP was 17.1% (RC-1). When we apply the RC-IV for DF, only 57.1% of the dyspeptic individuals and 13.6% of our GP fulfilled the criteria. The prevalence of FD in our GP was 9.5% (RC-IV) (Table 1). To conclude, the prevalence of FD in our GP was 17.1% (RC-I) or 9.5% (RC-IV), which means that we can assume a excluding rigidity (≈55% lower) with the actual RC-IV. The prevalence of dyspepsia and FD in different GP whose variability depends on epidemiologic factors and the rigidity of the applied criteria are shown in Table 1.

Table 1 Prevalence of dyspepsia and functional dyspepsia in different populations around the world (5) 

*Definition of dyspepsia: pain or upper abdominal discomfort, chronic or recurrent of at least 12 weeks duration, not necessarily consecutive, within the preceding 12 months (1). Figures from our study appear in parentheses.

Bibliografía

1. Talley NJ, Stanghellini V, Heading RC, et al. Functional gastroduodenal disorders. Gut 1999;45(Suppl 2):37-42. DOI: 10.1136/gut.45.2008.ii37 [ Links ]

2. Stanghellini V, Chan FKL, Hasler WL, et al. Gastroduodenal disorders. Gastroenterology 2016;150:1380-92. DOI: 10.1053/j.gastro.2016.02.011 [ Links ]

3. Aziz I, Palsson OS, Törnblom H, et al. Epidemiology, clinical characteristics, and associations for symptom-based Rome IV functional dyspepsia in adults in the USA, Canada, and the UK: a cross-sectional population-based study. Lancet Gastroenterol Hepatol 2018. En prensa. DOI: 10.1016/S2468-1253(18)30003-7 [ Links ]

4. Caballero Plasencia AM, Sofos Kontoyannis S, Valenzuela Barranco M, et al. Epidemiology of dyspepsia in a random Mediterranean population. Prevalence of Helicobacter pylori infection. Rev Esp Enferm Dig 2000;92:781-92. [ Links ]

5. Mahadeva S, Goh KL. Epidemiology of functional dyspepsia: a global perspective. World J Gastroenterol 2006;12:2661-6. DOI: 10.3748/wjg.v12.i17.2661 [ Links ]

Creative Commons License Este es un artículo publicado en acceso abierto bajo una licencia Creative Commons